Risperidone-Induced Obesity in Children and Adolescents With Autism Spectrum Disorder: Genetic and Clinical Risk Factors

Aims: Obesity is a significant problem for patients taking atypical antipsychotics. There were two aims of our study. The first aim was to compare the prevalence of overweight and obesity between children and adolescents with autism spectrum disorder (ASD) treated with risperidone with the general p...

Descripción completa

Detalles Bibliográficos
Autores principales: Vanwong, Natchaya, Ngamsamut, Nattawat, Nuntamool, Nopphadol, Hongkaew, Yaowaluck, Sukprasong, Rattanaporn, Puangpetch, Apichaya, Limsila, Penkhae, Sukasem, Chonlaphat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677569/
https://www.ncbi.nlm.nih.gov/pubmed/33240086
http://dx.doi.org/10.3389/fphar.2020.565074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677569/
https://www.ncbi.nlm.nih.gov/pubmed/33240086
http://dx.doi.org/10.3389/fphar.2020.565074

Ejemplares similares